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Over the last few decades Limulus Amebocyte Lysate (LAL) has been the most sensitive method for the
detection of endotoxins (Lipopolysaccharides) and is well accepted in a broad ﬁeld of applications.
Recently, Low Endotoxin Recovery (LER) in biopharmaceutical drug products has been noticed, whereby
the detection of potential endotoxin contaminations is not ensured. Notably, most of these drug products
contain surfactants, which can have crucial effects on the detectability of endotoxin. In order to analyze
the driving forces of LER, endotoxin detection in samples containing nonionic surfactants in various
buffer systems was investigated. The results show that the process of LER is kinetically controlled and
temperature-dependent. Furthermore, only the simultaneous presence of nonionic surfactants and
components capable of forming metal complexes resulted in LER. In addition, capacity experiments show
that even hazardous amounts of endotoxin can remain undetectable within such formulation compo-
sitions. In conclusion, the LER phenomenon is caused by endotoxin masking and not by test interference.
In this process, the supramolecular structure of endotoxin is altered and exhibits only a limited sus-
ceptibility in binding to the Factor C of Limulus-based detection systems. We propose a two-step
mechanism of endotoxin masking by complex forming agents and nonionic surfactants.
© 2016 The Author(s). Published by Elsevier Ltd on behalf of International Alliance for Biological
Standardization. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).1. Introduction
Endotoxins are products of Gram-negative bacteria, released
during bacterial cell division, lysis and at cell death. Chemically,
endotoxins are lipopolysaccharides (LPS). The general structure of
LPS comprises three basic units (Fig. 1), O-antigen, Core and Lipid A,
wherein the latter is the highly toxic part [1]. Within the
mammalian blood circulation, endotoxin can trigger severe physi-
ological reactions (e.g. fever, septic shock) [2,3]. Thus, bacterial
endotoxin testing of drug products for parenteral administration is
mandatory. However, several applications have shown that detec-
tion of endotoxin using widespread Limulus Amebocyte Lysate
(LAL) based methods are not always feasible in complex protein
samples containing endotoxin [4,5].82362 Weilheim, Germany.
h).
er Ltd on behalf of International Al
.One reason for inadequate detection of endotoxin is interference
of sample constituents with the enzymatic reaction of the Limulus-
based detection system. In this case, certain components (e.g. heavy
metals, protease inhibitors) candirectly disturb enzyme activation of
the detection system, which is called test interference [6]. This
phenomenon is well known and to indicate test interference, posi-
tive product controls are performed. To this end, a known amount of
endotoxin is added to the sample and immediately measured. A test
is considered valid if the spiked endotoxin is recovered in a range of
50e200%. If thevaliditycriterion isnot fulﬁlled, it is recommended to
overcome interference by suitable sample treatments such as dilu-
tion, ﬁltration, neutralization, dialysis or heating etc. [7]. Another
potential reason for inadequate endotoxin detection is the interac-
tion of endotoxin itself with matrix components of the sample. For
instance, it has been reported that endotoxin can interactwith blood
components [8], proteins [4] or amphiphilic molecules [9,10],
resulting in a signiﬁcant change of endotoxin activity. Notably, ap-
proaches which eliminate test interference problems are not effec-
tive in overcoming such effects [4]. In the 1990's Greaves and co-
workers [11] already differentiated between dilution dependentliance for Biological Standardization. This is an open access article under the CC BY
Fig. 1. Schematic structure of Lipopolysaccharides (LPS). LPS is an amphiphilic mole-
cule. The fatty acids within the Lipid A are hydrophobic and the polysaccharides in the
Core and O-antigen are hydrophilic. In addition, LPS is electrically charged due to
substitution (e.g. phosphates) in the core region and on the diglucosamine of Lipid A.
With regard to the biological nature, LPS can be divided into the three functional
subunits O-antigen, Core and Lipid A. The latter is the toxic fragment of the molecule.
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mental samples. The latter phenomenon is called masking.
In the recent past, inadequate endotoxin recovery over time has
been observed in biopharmaceutical drug products [12]. In such
cases, the active pharmaceutical ingredients are mostly proteins
[13], which are capable of intrinsic binding to endotoxin as previ-
ously described by Anspach and co-workers [4]. The inadequate
detection of endotoxin might be explained by protein-endotoxin
interactions. Nonetheless, therapeutic proteins are usually stabi-
lized by excipients, like nonionic surfactants and certain buffer
components [14]. Surprisingly, endotoxin spiking experiments in
formulations that lack the active pharmaceutical ingredient (e.g.
monoclonal antibody) resulted in endotoxin masking over time.
Such observations of disturbed endotoxin determinations in bio-
pharmaceutical products over time and the related risk of undis-
covered endotoxin contamination events compelled us to study the
impact of common formulation components on the detectability in
Limulus-based detection systems. The aim of the present study is to
understand the mechanism of Low Endotoxin Recovery (LER) in
samples containing nonionic surfactants in combination with
standard buffer systems.2. Materials & methods
E.coli O55:B5 lipopolysaccharide (gel-ﬁltered), polysorbate 20,
polysorbate 80, octoxynol 9, citric acid, trisodium citrate, phos-
phoric acid, sodium dihydrogen phosphate, disodium hydrogen
phosphate were obtained from SigmaeAldrich Chemicals, Stein-
heim, Germany. Depyrogenated water, depyrogenated borosilicate
glass tubes and recombinant Factor C test (EndoZyme®) were ob-
tained from Hyglos GmbH, Bernried, Germany. Kinetic chromo-
genic Limulus Amebocyte Lysate test was obtained from Lonza Inc.,
Walkersville, USA. Prior to the experiments, all relevant materials
were tested for endotoxin content and proven to contain less than
0.005 EU/mL.
Sample preparation: Samples were prepared in 5 mL glass tubes
with sample volumes of 1 mL per sample. Unless otherwise
described, samples were spiked with 10 mL of lipopolysaccharide(LPS) out of a 10,000 EU/mL stock solution. The pH of buffer com-
ponents was adjusted to 7.5, if not otherwise speciﬁed. Before
adding the spikes to the sample, the stock solution was shaken at
1400 rpm for 10 min. After spiking, the samples were incubated at
deﬁned temperatures and periods of time. Immediately after in-
cubation, the samples were mixed at 1400 rpm for 2 min again, and
diluted in depyrogenated water in order to avoid test interference.
Necessary dilutions of the particular sample compositions were
determined prior to the actual experiment.
Kinetics: All samples with different incubation periods were
measured on the same microtiter plate, to avoid variation from test
to test. Therefore, endotoxin recovery kinetics was performed in a
reverse manner. The particular sample was aliquoted and all ali-
quots were stored under equal conditions over time. The aliquot
with the longest endotoxin incubation period was spiked ﬁrst (e.g.
7 days prior to the measurement). Further aliquots with shorter
incubation periods were spiked later in accordance with the
respective incubation period. The zero time point aliquot was
spiked immediately before measurement. To control accuracy of
the spikes at different time points, equal amounts of endotoxin
were spiked into depyrogenated water (data not shown).
Detection of endotoxin: For detection of endotoxin, a recombi-
nant Factor C test (EndoZyme®) and a kinetic chromogenic Limulus
Amebocyte Lysate (LAL) test were used according tomanufacturer's
instructions. The released amount of ﬂuorescence substrate, using
the recombinant test, was measured spectrophotometrically at
440 nm with an FLx800 ﬂuorescence microplate reader (BioTek,
Bad Friedrichshall, Germany). All samples were measured in
duplicate and average values were used for further calculations.
Endotoxin concentrations (EU/mL) were calculated using Gen5
Data Analysis Software Version 2.05 (BioTek, Bad Friedrichshall,
Germany). Standard curves were ﬁt using a four parameter logistic
non-linear regression model. The detection limit of the assay was
0.005 EU/mL. For the LAL test, the released amount of chromogenic
substrate was measured spectrophotometrically at 405 nmwith an
Epoch2 absorbance microplate reader (BioTek, Bad Friedrichshall,
Germany). All samples were measured in duplicate and average
values were used for further calculations. Endotoxin concentrations
(EU/mL) were calculated using Gen5 Data Analysis Software
Version 2.05 (BioTek, Bad Friedrichshall, Germany). Standard curves
were ﬁt using a linear regressionmodel. Detection limit of the assay
was 0.005 EU/mL.
Calculation of endotoxin recovery [%]: The determined endotoxin
concentrations in the tested samples were compared to the endo-
toxin concentrations at time zero in positive controls and stated as
percent. Positive controls were prepared by spiking LPS into
depyrogenated water.
3. Results
LER was observed in various samples. In the beginning of the
study crucial formulation components of common bio-
pharmaceuticals were examined. Therefore, endotoxin masking of
single and multiple components were investigated. The end-point
of the reaction was determined by endotoxin recovery kinetics at
different temperatures. While multi-parameter interactions be-
tween surfactants, complex forming agents and endotoxin were
observed, the focus of the investigationwas the particular impact of
these components on the detectability of endotoxin. Thus, the
impact of pH and different buffer systems as well as the effects of
different nonionic surfactants were studied. Finally, various endo-
toxin concentrations were added to a LER causing formulation to
evaluate the masking capacity.
Single and mixtures of common formulation components were
examined to identify critical components or component
Table 1
Endotoxin recovery over time in presence of single and multiple formulation
components.
Sample Formulation components: T0 recovery [%] T7 recovery [%]
1 H2O 100 94
2 Sodium citrate 125 94
3 Sodium phosphate 95 69
4 Polysorbate 20 91 79
5 Sodium citrate þ
polysorbate 20
1 0
6 Sodium phosphate þ
polysorbate 20
52 0
Samples were spiked with an endotoxin amount of 10,000 EU/mL. Endotoxin was
detected after preparation (approx. 45 min., T0) and after sample incubation of
seven days (T7) at room temperature. Prior to the measurement samples were
diluted (1:1000 and 1:10,000).
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the presence of different formulation components are shown in
Table 1. The recovery was compared directly after sample prepa-
ration (T0) and after sample incubation for seven days (T7) at room
temperature. Samples 2, 3 and 4, containing only single componentFig. 2. Endotoxin recovery kinetics in citrate-polysorbate formulations. 100 EU/mL endoto
incubated for different time periods. The endotoxin recovery is plotted as a function of the in
21e23 C (:) and 2e8 C (-). For detection kinetic chromogenic LAL test (A) and recombi
independent replicates (n ¼ 3) of the sample. The replicates were measured on the same m
Fig. 3. Impact of buffer system on endotoxin recovery. (A): Effect of pH on endotoxin recover
plus 10 mM citrate (-), 0.05 wt % polysorbate 20 plus 10 mM phosphate (A), citrate only (▫
room temperature for seven days. The endotoxin recovery is shown as a function of the pH.
were added to solutions containing a buffer (5 mM EDTA (:), 10 mM sodium citrate (A) or
room temperature. The endotoxin recovery is plotted as function of the incubation time. The
sample. The replicates were measured on the same microtiter plate.additions showed no signiﬁcant loss of activity over time, according
to the validity criteria of 50%e200% of endotoxin recovery. In
contrast, endotoxin could not be measured in samples containing
both buffer and surfactant (samples 5 and 6) after an incubation
period of seven days. Therefore, the kinetics of endotoxin recovery
in samples containing polysorbate 20 and sodium citrate was
analyzed. Fig. 2 shows the endotoxin recovery of three identical
samples as a function of time at different incubation temperatures
(4 C, RT and 37 C) using a LAL test (A) and a recombinant Factor C
test (B) for detection. After a certain period of incubation, all sam-
ples showed low endotoxin recovery in both detection systems.
This result clearly indicates that this phenomenon is independent
of the test system. Furthermore, the loss of activity was signiﬁcantly
accelerated with increasing incubation temperature.
The latter experiments show that only the combination of a
buffer system and a surfactant results in LER. Thus, the impact of
different buffer systems was studied and is shown in Fig. 3. In order
to investigate pH dependency of endotoxin recovery over time,
different pH conditions were studied (Fig. 3A). In the absence of
surfactants, the variation of pH had no impact on endotoxinxin were added to samples containing 10 mM citrate and 0.05% polysorbate 20 and
cubation time. The different curves indicate incubation temperatures at 36e38 C (C),
nant Factor C tests (B) were used. The error bars reﬂect the standard deviation of three
icrotiter plate.
y: 100 EU/mL of endotoxin was added to solutions containing 0.05 wt % polysorbate 20
) and phosphate only (⋄). The pH varied in a range from 1 to 9 and incubation was at
(B): Effect of buffer systems on kinetics of endotoxin recovery: 100 EU/mL of endotoxin
10 mM sodium phosphate (-)) and 0.05 wt % polysorbate 20. Sample incubation was at
error bars reﬂect the standard deviation of three independent replicates (n ¼ 3) of the
Fig. 5. Endotoxin masking capacity of citrate-polysorbate formulation. Deﬁned
amounts of endotoxin were added to solutions containing 0.05 wt % polysorbate 20
and 10 mM sodium citrate and incubated for 7 days at 4 C. Endotoxin spikes were
prepared out of a LPS stock solution containing 10E6 EU/mL. After incubation,
endotoxin measurements were performed. The detectable endotoxin concentration
is shown in relation to the spiked endotoxin concentration.
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signiﬁcantly decreased at pH values higher than pH 2 (citrate sys-
tem) and pH 5 (phosphate system), respectively. Thus, the transi-
tion to higher pH values hampered endotoxin recovery. In addition,
the diverging curve progressions (Fig. 3A) indicate an intrinsic ef-
fect of each particular buffer system. Endotoxin recovery kinetics
using different buffer systems such as ethylenediaminetetraacetic
acid (EDTA), citrate and phosphate were studied and are shown in
Fig. 3B. The endotoxin recoverywithin the described buffer systems
are plotted as a function of time. The system containing EDTA
showed the most rapid activity loss. The loss of activity was slower
under citric conditions and slowest under phosphoric conditions.
After 6 h recovery was below 30% at each condition. As conﬁrmed
before, surfactants are signiﬁcantly involved in reducing the ac-
tivity of endotoxin in common detection systems. Therefore, the
effects of different surfactants at constant buffer and endotoxin
conditions were examined. In Fig. 4, the endotoxin recovery out of
surfactant solutions (polysorbate 20, polysorbate 80 and octoxynol
9) in presence and absence of citrate are plotted as a function of
surfactant concentration. In general, all surfactants signiﬁcantly
reduced endotoxin detectability in the presence of citrate after
seven days of incubation. In absence of citrate, only octoxynol 9
showed low recoveries at relatively high concentrations after the
incubation period.
Summarizing the results above, nonionic surfactants and com-
plex forming buffer components in combination cause a signiﬁcant
perturbation of endotoxin detection in Limulus-based detection
systems. The resulting LER is time-dependent and occurs solely
after a certain period of time. For a ﬁnal evaluation, the masking
capacity of such formulation matrices was examined. Endotoxin
was titrated into samples containing a citrate buffer system and
polysorbate. Fig. 5 shows the capacity of such a particular matrix.Fig. 4. Surfactant dependent endotoxin recovery. 100 EU/mL of endotoxin was added
to solutions containing various amounts of polysorbate 20 (A), polysorbate 80 (B) or
octoxynol 9 (C). Endotoxin recoveries were determined in the presence of 10 mM
citrate immediately after preparation (▫) and after incubation for 7 days at room
temperature (-). In parallel endotoxin activities were determined in the absence of
citrate, without incubation (▵) and after incubation (:). Endotoxin recovery is shown
as a function of the particular surfactant concentration.Spiked endotoxin contents of up to 250 EU/mL resulted in no
endotoxin recovery after seven days of incubation. Medium and
high-level spikes resulted in very low (<1%) and low endotoxin
(<5%) recovery. This illustrates the high masking capacity of com-
mon formulation matrices and suggests the need for vigilance in
bacterial endotoxin testing under such conditions.
4. Discussion
When less than 50% of an endotoxin spike into an undiluted
sample is recovered over time, the detection of endotoxin is
popularly classiﬁed as LER. It is supposed that this phenomenon is
caused by endotoxin masking. Therefore it is important to differ-
entiate this phenomenon from test interference. Test interference,
which directly affects the detection system, can be excluded
because it can be corrected by dilution. Yet, in the case of LER,
endotoxin dilutions up to a factor of 10,000 could not overcome
inadequate recovery (Table 1). Furthermore, within very short in-
cubation periods with endotoxin in the sample, the full endotoxin
content could be recovered, which illustrates the functionality of
the detection system. These ﬁndings reﬂect a previous observation,
namely that under certain condition the interference in Limulus-
based detection methods is concentration independent and as-
sumes that the aggregate conformation of LPS is affected and not
the detection system itself [11]. The assumption of alterations in the
aggregate conformation is supported by the time-dependent
appearance of LER. Obviously, the kinetics in Fig. 2 shows a time-
dependent phenomenon, while test interference appears immedi-
ately and is therefore time-independent. This time-dependent
behavior can be illustrated by an alteration of the supramolecular
structure of the amphiphilic LPS. In general, the process of aggre-
gation of amphiphilic molecules can be very variable with respect
to time-scales for structural changes, which can range from sub-
microseconds to several days, weeks and even month [15]. This
also might explain experimental results, in which the masking
phenomenonwas not observed, although masking conditions were
present [16].
However, the results also demonstrate that endotoxin recovery is
affected by the formulation components themselves, even if the
active pharmaceutical substance, such as a protein, is absent. The
simultaneous presence of a nonionic surfactant and complex
forming components (chelator) sufﬁces todecrease the detectability
of endotoxin. The presence of only one of the formulation compo-
nents is not effective in signiﬁcantly disturbing endotoxin recovery
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disaggregation [17,18] and explain the interdependent interaction of
surfactant and chelator on endotoxin. Due to the ionic and amphi-
philic nature of LPS (Fig. 1), complex forming agents disturb the
electrostatic interactions and surfactants potentially disturb the
hydrophobic interactions in endotoxin aggregates. Certainly, to
disturb the supramolecular structure of endotoxin a reduced rigidity
is beneﬁcial. This is controlled by the salt form of LPS, which again
involves the presence of multivalent cations like Ca2þ [19,20].
Consequently, it can be assumed that complex forming agents are in
competition with negatively charged patches of the endotoxin.
Therefore the salt bridges between LPS molecules are disturbed,
which should result in a reduced rigidity of endotoxin aggregates,
which in turn facilitates changes in the supramolecular structure.
Thus, the chelating capability of the buffer component is crucial. In
the presence of EDTA the recovery drops faster than in the presence
of citrate or phosphate based buffer systems (Fig. 3b). Using buffer
components with higher metal complex forming capabilities
accelerate masking kinetics. The related metal complex formation
constants are directly proportional to the denticity of the ligand
(rule of thumb [21]). A hexadentate ligand like EDTA forms more
stable metal complexes than a tridentate ligand like citrate.
Furthermore, the equilibrium complex formation ability and the
complex stability of a chelator are pH dependant. At low pH values,
protons are in competitionwith cations,which hamper formation of
metal complexes [22]. Consequently, masking of endotoxin is
affected by the free concentration of protons (pH), which is
controlled by the buffer system and its particular acid dissociation
constant. This explains the pH dependent endotoxin recovery in
different buffer systems (Fig. 2A). However, complex forming com-
ponents alone do not result in inadequate endotoxin detection,
further amphiphilic components like surfactants are necessary. Due
to the fact that LPS itself is amphiphilic, it tends to aggregate,
because of the lowsolubility of the hydrophobic fatty acids of Lipid A
in an aqueous solution [23]. Thus, LPS exhibits certain supramo-
lecular structures, which inﬂuence detectability in Limulus-based
detection systems [24]. Structural transitions of amphiphilic sys-
tems are affected by a large variety of physical and chemical pa-
rameters. Onemajor principle to control these structures is the head
group repulsions of self-assemblingmolecules. They can be affected
by co-surfactants, electrolytes, and amphiphilic counter ions [25]. If
the masking surfactant (e.g.: polysorbate) intercalates between LPS
molecules resulting in reduction of head group repulsions, the
establishment of a new equilibrium is favored and the supramo-
lecular structure of LPS is altered.Fig. 6. A proposed two-step mechanism of endotoxin masking. Potential equilibration re
schematically illustrated. In a ﬁrst step, pure endotoxin aggregates are disturbed by chelators
by forming mixed aggregates.The interaction of nonionic surfactants with LPS aggregates is
favored if the LPS aggregates possess a certain degree of rigidity
(Fig. 4). The latter is controlled, to some extent, by ionic interactions
as described above. Under these circumstances the supramolecular
structure of LPS is changed into a structure with a lower afﬁnity to
the endotoxin sensitive Factor C of the Limulus-based detection
system resulting in the measurement of a lower activity. Such a
structure could be disaggregated LPS due to a molecular excess of
surfactants. This hypothesis ﬁts well to the observation of Mueller
et al., which have shown that disaggregated LPS molecules
(“monomers”) are substantially less active than aggregated LPS in
the detection system used [24]. Additionally, Tan et al. proposed a
cooperative binding mechanism of LPS to Factor C, which conse-
quently requires more than one LPS molecule in close spatial ar-
rangements [26]. On the other hand, it has been shown that
monomeric LPS shows a higher potency in activating Limulus
Amebocyte Lysate assays than aggregated LPS [27]. Under these
circumstances, the inadequate detectability might have steric rea-
sons, inwhich the activating spots of the LPS (lipid A) are hidden by
surfactant molecules and are not accessible for Factor C.
In summary, we propose a two-step mechanism of endotoxin
masking. Fig. 6 illustrates the effects of chelating buffer compo-
nents and nonionic surfactants on endotoxin. In this mechanism
the equilibrium LPS structure is shifted to an altered supramolec-
ular structure. In its natural state, LPS monomers tend to aggregate
due to the hydrophobic interactions between the Lipid Amolecules.
Additional ionic interactions, formed by divalent cations and
negatively charged substitutes (e.g.: phosphates) of the LPS in-
crease the rigidity of aggregates. By adding a complex forming
agent (I), the salt bridges formed by divalent cations (e.g. Mg2þ)
and LPS are destabilized, leading to a reduced rigidity of the
aggregate. The further presence of a surfactant (II) can then change
the initial supramolecular structure by formation of mixed aggre-
gates. This structural change leads inevitably to a certain change in
detectable activity, as endotoxin activity is dependent on its su-
pramolecular structure. Due to the ordinary molar excess of com-
plex forming agent and surfactant (micro molar range), compared
to endotoxin content (nanomolar range), mixed surfactantmicelles
containing monomerized LPS are the most probable resulting su-
pramolecular structure.
Within this study, the phenomenon of LER were conﬁrmed in
Limulus-based detection systems and exempliﬁes a potential
mechanism of endotoxin masking. The unknown period of endo-
toxin presence during a potential event of endotoxin contamination
in a sample deﬁnes the chance of endotoxin recovery. Hence, LER isaction of endotoxin masking, caused by complex forming agents and surfactants, is
increasing the permeability of the aggregate. Then, surfactants interact with endotoxin
J. Reich et al. / Biologicals 44 (2016) 417e422422under control of kinetics that governs the formation of mixed
endotoxin-surfactant aggregates, which make them less prone to
activate the enzymatic reaction of Limulus-based detection sys-
tems. In conclusion, capacity experiments have shown that
commonly used excipients are capable of masking hazardous
amounts of endotoxin. Currently, it is not known whether masked
endotoxin activates the innate immune system. Bacterial endotoxin
testing should be performedwith care, especially in the presence of
surfactants and chelators.
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